Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Parrott

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 5, 2012
Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlusAki T Heikkinen, Guillaume Baneyx, Antonello Caruso, et al.
Proteomics. Clinical Applications|February 14, 2015
The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug developmentAki T Heikkinen, Floriane Lignet, Paul Cutler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Successful renal transplant during the first trimester of pregnancyLouise C Kenny, Philip N Baker, Michael Venning, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 26, 2016
Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) InhibitorPaul Barrow, Neil Parrott, Daniela Alberati, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2014
Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administrationGuillaume Baneyx, Neil Parrott, Christophe Meille, et al.
Molecular Pharmaceutics|April 27, 2022
Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug DiscoveryDoha Naga, Neil Parrott, Gerhard F Ecker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2021
Accelerating Clinical Development of Idasanutlin through a Physiologically Based Pharmacokinetic Modeling Risk Assessment for CYP450 Isoenzyme-Related Drug-Drug InteractionsKenichi Umehara, Yumi Cleary, Stephen Fowler, et al.
The AAPS Journal|October 9, 2020
Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and ZidovudineLuca Docci, Kenichi Umehara, Stephan Krähenbühl, et al.
Molecular Pharmaceutics|September 15, 2023
A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic ModelingAndrea Andrews-Morger, Michael Reutlinger, Neil Parrott, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 18, 2023
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainmentChristopher A Darlow, Neil Parrott, Richard W Peck, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 5, 2012
Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates - an evaluation and case study using GastroPlusAki T Heikkinen, Guillaume Baneyx, Antonello Caruso, et al.
Proteomics. Clinical Applications|February 14, 2015
The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug developmentAki T Heikkinen, Floriane Lignet, Paul Cutler, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Successful renal transplant during the first trimester of pregnancyLouise C Kenny, Philip N Baker, Michael Venning, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|May 26, 2016
Preclinical Reproductive and Developmental Toxicity Profile of a Glycine Transporter Type 1 (Glyt1) InhibitorPaul Barrow, Neil Parrott, Daniela Alberati, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2014
Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: influence of time between substrate and inducer administrationGuillaume Baneyx, Neil Parrott, Christophe Meille, et al.
Molecular Pharmaceutics|April 27, 2022
Evaluation of the Success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) Modeling Predictions to Inform Early Drug DiscoveryDoha Naga, Neil Parrott, Gerhard F Ecker, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2021
Accelerating Clinical Development of Idasanutlin through a Physiologically Based Pharmacokinetic Modeling Risk Assessment for CYP450 Isoenzyme-Related Drug-Drug InteractionsKenichi Umehara, Yumi Cleary, Stephen Fowler, et al.
The AAPS Journal|October 9, 2020
Construction and Verification of Physiologically Based Pharmacokinetic Models for Four Drugs Majorly Cleared by Glucuronidation: Lorazepam, Oxazepam, Naloxone, and ZidovudineLuca Docci, Kenichi Umehara, Stephan Krähenbühl, et al.
Molecular Pharmaceutics|September 15, 2023
A Machine Learning Framework to Improve Rat Clearance Predictions and Inform Physiologically Based Pharmacokinetic ModelingAndrea Andrews-Morger, Michael Reutlinger, Neil Parrott, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 18, 2023
Development and application of neonatal physiology-based pharmacokinetic models of amikacin and fosfomycin to assess pharmacodynamic target attainmentChristopher A Darlow, Neil Parrott, Richard W Peck, et al.
Pageof 13